申请人:Blancou Hubert
公开号:US20080015255A1
公开(公告)日:2008-01-17
Pharmacuetical composition comprising compounds of formula (I):
NZ
1
Z
2
Z
3
(I)
in which:
Z
1
, Z
2
, Z
3
each independently of the others represents: a hydrogen atom;
C
1
-C
6
-alkyl group;
a group —SO
2
R
3
wherein R
3
represents a linear or branched C
1
-C
12
-alkyl, -alkenyl or -alkynyl group, a C
3
-C
10
-cycloalkyl group or a C
6
-C
10
-aryl group, a (C
1
-C
6
)-alkyl-(C
6
-C
14
)-aryl group, or a C
5
-C
10
-heteroaryl group;
it being understood that at least one of the groups Z
1
, Z
2
, Z
3
represents a group of formula (II)
X—R
F
—(CH
2
)
n
—SO
2
— (II)
X, RF and n being as defined in claim
1.
含有以下式(I)的化合物的药物组合物:NZ1Z2Z3(I)其中:Z1、Z2、Z3分别独立地表示:氢原子;C1-C6-烷基团;—SO2R3基团其中R3表示线性或支链的C1-C12烷基、烯基或炔基团、C3-C10环烷基团或C6-C10芳基团、(C1-C6)-烷基-(C6-C14)-芳基团或C5-C10杂环芳基团;理解至少有一个Z1、Z2、Z3基团表示如下式(II)的基团X—RF—(CH2)n—SO2— (II)其中X、RF和n如权利要求1中定义。